Comments

Xenon Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

XENENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$34.60

-0.72-2.04%

Pre-Market: 5:04 AM EDT

Xenon Pharmaceuticals (XENE) Forecast

News Earnings Xenon Pharmaceuticals (XENE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Xenon Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:XENE | Benzinga

Explore Xenon Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XENE.

Open	-
Close	-
Volume / Avg.	529.00 / 449.56K
Day Range	- - -
52 Wk Range	33.27 - 46.00
Market Cap	$2.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	4.95%
Days to Cover	7.05

Recent News

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.

Vandana Singh

Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today

Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares are trading higher by 7.8% to $36.38 Thursday afternoon. The company announced the pricing of its upsized $300 million public offering of 8,461,542 common shares at

Henry Khederian

Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	529.00 / 449.56K
Day Range	- - -
52 Wk Range	33.27 - 46.00
Market Cap	$2.65B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	4.95%
Days to Cover	7.05

About

Sector

Healthcare

Industry

N/A

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Xenon Pharmaceuticals (XENE) stock?

You can purchase shares of Xenon Pharmaceuticals (NASDAQ:XENE) through any online brokerage.

View our list of the best stock brokerages

Who are Xenon Pharmaceuticals (XENE) competitors?

There are no as such competitors for Xenon Pharmaceuticals.

What is the forecast, or price target, for Xenon Pharmaceuticals (XENE) stock?

Xenon Pharmaceuticals has a consensus price target of $56.35.

What is the current price for Xenon Pharmaceuticals (XENE)?

The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $34.6 last updated March 17, 2025 at 5:04 AM EDT.

Does Xenon Pharmaceuticals (XENE) pay a dividend?

There are no upcoming dividends for Xenon Pharmaceuticals.

When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?

Xenon Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Xenon Pharmaceuticals (XENE) going to split?

There is no upcoming split for Xenon Pharmaceuticals.

What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.